https://www.selleckchem.com/pr....oducts/trastuzumab-d
68, p.001) and uncontrolled eating (β=-4.05, p=.03), and increase in cognitive restrained eating (β=5.53, p.01), compared to no F-BA. The effect of the F-BA therapy on emotional and uncontrolled eating was stronger in those with higher baseline depressive symptoms (IDS-SR). The F-BA did also lead to small improvements in MDS (β=1.95, p.001), but not to change in body weight. Our trial showed no reduction in bodyweight, but provides support for the possibility to improve both unhealthy eating styles and diet qu
Beğen
Yorum Yap
Paylaş
